Encapsulated Glioma — Trials

Encapsulated Glioma — Trials · CancerIndex

Clinical trials

Registered studies

328 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 116
Recruiting: 55
Ph III recruiting: 5
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 40.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (51)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05233215	GROW (Glioma Specialists Reaching Out With Support) Support	withdrawn	N/A	0	Dana-Farber Cancer InstituteOTHER	1	Jan 5, 2023	clinicaltrials
NCT03353896	NovoTTF-200A Device in Treating Patients With Newly Diagnosed High Risk Oligodendroglioma	withdrawn	N/A	0	University of Southern CaliforniaOTHER	1	Dec 10, 2020	clinicaltrials